Authors: GILLIAM BL DYER JR FISCUS SA MARCUS C ZHOU S WATHEN L FREIMUTH WW COHEN MS ERON JJ

Citation: Bl. Gilliam et al., EFFECTS OF REVERSE-TRANSCRIPTASE INHIBITOR THERAPY ON THE HIV-1 VIRALBURDEN IN SEMEN, Journal of acquired immune deficiency syndromes and human retrovirology, 15(1), 1997, pp. 54-60

Authors: DAVEY RT CHAITT DG REED GF FREIMUTH WW HERPIN BR METCALF JA EASTMAN PS FALLOON J KOVACS JA POLIS MA WALKER RE MASUR H BOYLE J COLEMAN S COX SR WATHEN L DAENZER CL LANE HC

Citation: Rt. Davey et al., RANDOMIZED, CONTROLLED PHASE I II TRIAL OF COMBINATION THERAPY WITH DELAVIRDINE (U-90152S) AND CONVENTIONAL NUCLEOSIDES IN HUMAN-IMMUNODEFICIENCY-VIRUS TYPE 1-INFECTED PATIENTS/, Antimicrobial agents and chemotherapy, 40(7), 1996, pp. 1657-1664

Authors: DAVEY RT BOENNING CM HERPIN BR BATTS DH METCALF JA WATHEN L COX SR POLIS MA KOVACS JA FALLOON J WALKER RE SALZMAN N MASUR H LANE HC

Citation: Rt. Davey et al., USE OF RECOMBINANT SOLUBLE CD4 PSEUDOMONAS EXOTOXIN, A NOVEL IMMUNOTOXIN, FOR TREATMENT OF PERSONS INFECTED WITH HUMAN-IMMUNODEFICIENCY-VIRUS, The Journal of infectious diseases, 170(5), 1994, pp. 1180-1188